Emerald Advisers, LLC

SEC CIK: 0001015083
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of APLS by Emerald Advisers, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−7,751−100.0%	Sold out	Holders
Q1 2024	7,751	$455.6K	<0.1%	+3,515+83.0%	Added	Holders
Q4 2023	4,236	$253.6K	<0.1%	+4,236	New	Holders